Kyntra Bio (KYNB) Inventory (2018 - 2026)

Kyntra Bio has disclosed Inventory across 9 years of filings, most recently posting $3.4 million for Q2 2026.

• In Q2 2026, Inventory fell 12.4% year-over-year to $3.4 million; the TTM figure through Jun 2026 stood at $3.4 million (down 12.4% YoY), while the FY2025 annual figure was $3.7 million, up 18.64% from the prior year.
• Inventory came in at $3.4 million for Q2 2026 at Kyntra Bio, roughly flat from $3.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $43.1 million in Q1 2022 to a low of $3.2 million in Q4 2024.
• Average Inventory over 5 years is $22.6 million, with a median of $24.7 million recorded in 2024.
• Year-over-year, Inventory surged 107.41% in 2022 and sank 88.46% in 2025.
• Over 5 years, Inventory stood at $40.4 million in 2022, then slumped by 57.53% to $17.2 million in 2023, then tumbled by 81.63% to $3.2 million in 2024, then climbed by 18.64% to $3.7 million in 2025, then slipped by 9.59% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $3.4 million in Q2 2026, $3.4 million in Q1 2026, and $3.7 million in Q4 2025.